Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 22124170)

1.

Chronic kidney disease: Endogenous filtration markers--is it time to move beyond eGFR?

Rule AD, Elsherbiny H.

Nat Rev Nephrol. 2011 Nov 29;8(1):10-2. doi: 10.1038/nrneph.2011.193. No abstract available.

PMID:
22124170
2.
3.

Is cystatin C the answer to detecting progression in CKD?

de Jong PE, Gansevoort RT.

J Am Soc Nephrol. 2011 Jan;22(1):9-11. doi: 10.1681/ASN.2010111189. Epub 2010 Dec 16. No abstract available.

4.

Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction.

Kato K, Takata Y, Usui Y, Shiina K, Asano K, Hashimura Y, Saruhara H, Nishihata Y, Tomiyama H, Yamashina A.

Respir Med. 2011 Apr;105(4):643-9. doi: 10.1016/j.rmed.2010.11.024. Epub 2010 Dec 22.

5.

Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.

Sato H, Kuroda T, Tanabe N, Ajiro J, Wada Y, Murakami S, Sakatsume M, Nakano M, Gejyo F.

Scand J Rheumatol. 2010;39(1):33-7. doi: 10.3109/03009740903042402.

PMID:
20132068
6.

Estimation of glomerular filtration rate with creatinine-based versus cystatin C-based equations in kidney transplant recipients.

Savaj S, Shoushtarizadeh T, Abbasi MA, Razavimanesh SH, Ghods AJ.

Iran J Kidney Dis. 2009 Oct;3(4):234-8.

7.

Decreased kidney function in the elderly: clinical and preclinical, neither benign.

Coresh J, Astor B.

Ann Intern Med. 2006 Aug 15;145(4):299-301. No abstract available.

PMID:
16908921
8.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
9.

[Chronic renal insufficiency and cardiovascular disease].

Charriere S, Rognant N, Chiche F, Cremer A, Deray G, Priou M.

Ann Cardiol Angeiol (Paris). 2009 Feb;58(1):40-52. doi: 10.1016/j.ancard.2008.07.010. Epub 2008 Aug 19. Review. French.

PMID:
18937921
10.

[Could cystatine C replace creatinine as a market of glomerular filtration rate?].

Chollet-Dallon E, Stoermann-Chopard C, Martin PY.

Rev Med Suisse. 2006 Mar 1;2(55):582-5. Review. French.

PMID:
16562601
11.

Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations.

Weinert LS, Camargo EG, Soares AA, Silveiro SP.

Clin Chem Lab Med. 2011 Nov;49(11):1761-71. doi: 10.1515/CCLM.2011.670. Epub 2011 Jul 14. Review.

PMID:
21756163
12.

[Chronic kidney disease what is it?].

Joly D.

Rev Prat. 2012 Jan;62(1):34-7. French.

PMID:
22335064
13.

Estimating and measuring glomerular filtration rate in children.

Work DF, Schwartz GJ.

Curr Opin Nephrol Hypertens. 2008 May;17(3):320-5. doi: 10.1097/MNH.0b013e3282fb77f2. Review.

PMID:
18408486
14.

The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.

Boudville N, Salama M, Jeffrey GP, Ferrari P.

Nephrol Dial Transplant. 2009 Sep;24(9):2926-30. doi: 10.1093/ndt/gfp255. Epub 2009 Jun 8.

15.

Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.

Delaney MP, Stevens PE, Al Hasani M, Stowe HJ, Judge C, Lamb EJ.

Am J Kidney Dis. 2008 Feb;51(2):278-84. doi: 10.1053/j.ajkd.2007.08.018.

PMID:
18215705
16.
17.

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.

Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S.

Ren Fail. 2008;30(6):625-8. doi: 10.1080/08860220802134607.

PMID:
18661413
18.
19.

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study.

Akerblom Å, Wallentin L, Siegbahn A, Becker RC, Budaj A, Buck K, Giannitsis E, Horrow J, Husted S, Katus HA, Steg PG, Storey RF, Åsenblad N, James SK.

Clin Chem. 2012 Jan;58(1):190-9. doi: 10.1373/clinchem.2011.171520. Epub 2011 Nov 29.

20.

Cystatin C versus creatinine for kidney function-based risk.

Vandecasteele SJ, De Vriese AS.

N Engl J Med. 2013 Dec 19;369(25):2458-9. doi: 10.1056/NEJMc1312801#SA3. No abstract available.

PMID:
24350962
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk